DREAM 2014.

Trial name or title	DRy Eye Assessment and Management study (DREAM)
Methods	RCT
Participants	Adults with dry eye
Interventions	Each for 2 years Arm 1: omega‐3 supplements (2000 mg EPA + 1000 mgDHA/d as 5 gel caps) Arm 2: olive oil supplements (5 gel caps)
Outcomes	Primary: OSDI score (ocular surface disease index) Secondary: other eye health measures, SF‐36, healthcare utilisation costs, cost‐effectiveness
Starting date	Registered on Trials Registry 28 April 2014 Study start date: November 2014 Estimated study completion date: July 2017
Contact information	Penny Asbell, Mount Sinai Icahn School of Medicine (Study Chair), Maureen Maguire, University of Pennsylvania (PI)
Notes	NCT02128763